Overview
Richard Heyman is a Venture Partner at ARCH Venture Partners [1][8]. Heyman holds a PhD in Pharmacology from the University of Minnesota [10]. Heyman serves as Chairman of the Board at PMV Pharmaceuticals, Inc. [7], Chairman of the Board at ORIC Pharmaceuticals [4], and Chairman of the Board at Enliven Therapeutics [5]. Heyman also holds board positions at Architect Therapeutics as Chairman and Co-Founder [3], Vividion Therapeutics as a board member and former Chairman [6], and Pelage Pharmaceuticals [2]. Additionally, Heyman serves as a Science Partner at Nextech Invest [9].
Career history
- Board MemberOct 2025 to presentPelage Pharmaceuticals
- Chairman of the BOD and Co-FounderAug 2023 to presentArchitect Therapeutics
- Chairman of the BODNov 2014 to presentORIC Pharmaceuticals
- BOD Member/Chairman2020 to presentEnliven Therapeutics
- BOD member/Former Chairman2018 to presentVividion Therapeutics, Inc.
- Chairman of the Board2020 to presentPMV Pharmaceuticals, Inc.
- Venture Partner2020 to presentARCH Venture Partners
- Science PartnerMay 2022 to presentNextech Invest
Education
PhD, Pharmacology1980 - 1986University of Minnesota
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.